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SUMMARY
Background and Objective：Chronic interstitial pneumonia （IP） might include chronic hypersensitivity 
pneumonitis （HP） and chronic bird-related hypersensitivity pneumonitis （BRHP）. A specific antigen is diffi-
cult to identify in these diseases, and such evidence would provide important clues suggesting a diagnosis of 
HP. In this study, we used an ImmunoCAP analysis system to measure specific IgG antibodies against pi-
geons and budgerigars in the sera of patients with IP and investigated the involvement of bird-related IgG 
antibodies in IP.
Methods：The study group comprised 22 patients with idiopathic pulmonary fibrosis （IPF）, 8 with chron-
ic IP, 7 with subacute HP, 7 with chronic HP, and 10 with control diseases. All cases were diagnosed from 
2000 through 2011 at the Institute of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical Uni-
versity. Clinical features, results of laboratory examinations, and levels of serum IgG antibodies against pi-
geons and budgerigars were compared.
Results：There were no significant differences among the disease groups in C-reactive protein, leukocyte 
count, lactate dehydrogenase, and the results of blood gas analysis. KL-6 and surfactant protein D were sig-
nificantly higher in subacute HP and chronic HP. The levels of anti-pigeon IgG antibodies and anti-budgeri-
gar IgG antibodies in each disease group were respectively as follows：IPF, 11 .02±5.97 mg/l, 5 .03±
3.97 mg/l；chronic IP, 10.04±8.55 mg/l, 3.30±1.47 mg/l；subacute HP, 14.39±9.13 mg/l, 7.96±6.47 mg/l；
chronic HP, 24.97±16.19 mg/l, 11.50±13.80 mg/l；and control diseases, 8.66±3.15 mg/l, 3.77±1.05 mg/l. 
The mean levels of anti-pigeon IgG antibodies and anti-budgerigar IgG antibodies were significantly higher 
in chronic HP. There was a positive correlation between anti-pigeon IgG antibodies and anti-budgerigar 
IgG antibodies （R2 ＝ 0.715, p＜0.001）. 
Conclusions：In patients with clinically diagnosed chronic HP, high levels of anti-pigeon IgG antibodies 
or anti-budgerigar IgG antibodies were confirmed using an ImmunoCAP analysis system. In general, HP 
（especially chronic HP） is difficult to diagnose definitively, and this analysis system is expected to facilitate 
diagnosis.
Key Words： idiopathic pulmonary fibrosis, chronic interstitial pneumonia, chronic hypersensitivity pneu-
monitis, bird-related hypersensitivity pneumonitis
Abbreviations：
BAL＝bronchoalveolar lavage
BRHP＝bird-related hypersensitivity pneumonitis
HP＝hypersensitivity pneumonitis
HRCT＝high-resolution computed tomography
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INTRODUCTION
Hypersensitivity pneumonitis （HP） is an allergic 
lung disease （allergic alveolitis） caused by repeated 
inhalation of organic or inorganic dust antigens1） and 
is classified as acute, subacute or chronic2）. Specific an-
tigens are difficult to identify, especially in chronic HP. 
During the course of disease, cough and dyspnea in-
crease in association with irreversible progression of 
pulmonary fibrosis and emphysema. Previous studies 
have reported that chronic interstitial pneumonia （IP） 
may include chronic HP and chronic bird-related hy-
persensitivity pneumonitis （BRHP）3）. The clinical 
course of chronic HP is similar to that of idiopathic pul-
monary fibrosis （IPF）, and diagnosis on high-resolu-
tion computed tomography （HRCT） of the chest re-
mains challenging. Chronic HP is also difficult to 
diagnose on microscopical examination of lung speci-
mens obtained by surgical biopsy.
A variety of antigens, including fungi, bacteria, ani-
mal proteins, and chemical substances, can potentially 
cause chronic HP, and bird-associated antigens, such 
as bird droppings and feathers, are important4）. Proof 
of specific antibodies against these antigens would pro-
vide useful clues suggesting a diagnosis of HP. Anti-
body testing against bird-related antigens might be 
possible at special laboratories, but is still not widely 
performed clinically. In this study, we used an Immu-
noCAP analysis system to measure specific IgG anti-
bodies against pigeons and budgerigars in the sera of 
patients with IP5,6） and investigated the involvement of 
bird-related IgG antibodies.
MATERIAL AND METHODS
Patients
The study group of this retrospective study com-
prised 22 patients with IPF, 8 with chronic IP, 7 with 
subacute HP, 7 with chronic HP, and 10 with control 
diseases （lung cancer, 4；pneumonia, 4；and chronic 
obstructive pulmonary disease ［COPD］, 2）. All cases 
were diagnosed during the 1 2 years from 2 0 0 0 
through 2011 at the Institute of Pulmonary Medicine 
and Clinical Immunology, Dokkyo Medical University. 
Clinical data were obtained from patient records. Clini-
cal features, results of laboratory examinations, and 
levels of serum IgG antibodies against pigeons and 
budgerigars were compared among the disease groups.
Major diagnostic criteria for IPF were as follows：
（1） exclusion of known interstitial lung diseases such 
as collagen vascular disease, environmental exposure, 
and drug-induced pneumonitis；（2） restrictive impair-
ment of pulmonary function and arterial blood gas ex-
change failure；and （3） bilateral reticular or ground-
glass opacities accompanied by honeycombing in basal 
lung lesions on chest HRCT. Secondary diagnostic cri-
teria were （1） an age of 50 years or older, （2） slow 
progression of respiratory problems, （3） a disease du-
ration of 3 months or longer, and （4） fine crackles in 
both basal lung fields. A clinical diagnosis of IPF re-
quired that all three major diagnostic criteria and at 
least three of the four secondary diagnostic criteria 
were met. If surgical lung biopsy was performed and 
confirmed a usual interstitial pneumonia （UIP） pat-
tern, the findings of honeycombing on chest HRCT 
were excluded from the major criteria.
Definition and diagnosis of chronic IP is based on 
the exclusion of known drug-induced pneumonitis, 
pneumoconiosis, environmental exposure, and collagen 
vascular disease associated with interstitial lung dis-
ease （ILD）. If the diagnostic criteria for IPF or other 
idiopathic interstitial pneumonias （IIPs） are not met, 
chronic IP is diagnosed.
The diagnostic criteria for acute or subacute HP 
were as follows：（1） cough, shortness of breath, fever, 
fine crackles；（2） diffuse centrilobular granular or 
ground-grass opacities on chest HRCT, restrictive pul-
monary function impairment, hypoxemia, evidence of 
inflammation on blood tests, lymphocytosis in broncho-
alveolar lavage fluid （BALF）, and a negative tubercu-
lin reaction；（3） positive specific antibodies against 
trichosporon species （summer type HP）；（4） symp-
tom flare-up caused by home or occupational expo-
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sure；and （5） confirmation of granuloma, alveolitis, or 
Masson bodies on microscopical examination of a biop-
sy specimen of the lung, satisfying the diagnostic crite-
ria for HP proposed by the Japanese Ministry of 
Health, Labour and Welfare7）. 
The diagnostic criteria for chronic HP were as fol-
lows：（1） environmental exposure to various anti-
gens；（2） fine crackles in chest；（3） lymphocytosis in 
BALF or positive results of an induced lymphocyte 
proliferation test；（4） diffuse centrilobular granular or 
ground-grass opacities on chest HRCT；（5） pathologi-
cal findings of chronic HP on surgical lung biopsy；（6） 
clinical flare-ups caused by environmental exposure；
（7） progression of restrictive impairment of pulmo-
nary function for more than 1 year or related symp-
toms lasting for 6 months or longer；and （8） positive 
results of antigen inhalation provocation tests or im-
provement of symptoms in response to antigen avoid-
ance.
Measurement of specific antibodies
We measured specific IgG antibodies against pigeons 
and budgerigars with the use of an ImmunoCAP anal-
ysis system （Phadia100；Phadia Inc., Uppsala, Swe-
den）5,6）. The antigens were pigeon serum （Ge93）, 
droppings （e7）, and feathers （Re215）, and budgerigar 
serum （e79）, feathers （e78）, and droppings （e77）. 
When all reagents were in excess, the fluorescence 
was proportional to the concentration of serum IgG an-
tibody, and the titer was calculated by interpolation 
onto a 6-point standard curve generated by the fluo-
rescence from standard samples of known IgG titer.
Statistical Analysis
Data are expressed as means±SD. Differences be-
tween groups were analyzed using nonparametric 
methods （Mann-Whitney U test）. Spearman rank cor-
relation coefficients were used to explore the relation-
ship between the levels of serum IgG antibodies 
against pigeons and budgerigars. Clinical data analysis 
was performed with statistical software （JMP 10.0；
SAS Institute Inc., Cary, NC, USA）. Statistical signifi-
cance was defined as a p value of less than 0.05.
RESULTS
Characteristics of patients （Table 1）
The subjects were 22 patients with IPF （mean age, 
65 . 8 years；16 men, 6 women）, 8 with chronic IP 
（mean age, 67.5 years；3 men, 5 women）, 7 with sub-
acute HP （mean age, 53.9 years；3 men, 4 women）, 7 
with chronic HP （mean age, 63 . 4 years；4 men, 3 
women）, and 10 with control disease （mean age, 58.9 
years；6 men, 4 women）. In pulmonary-function test-
ing, the mean value of VC％ predicted was significant-
ly higher in subacute HP than in IPF.
Laboratory findings at diagnosis （Table 2）
There was no significant difference among the dis-
ease groups in C-reactive protein, leukocyte count, lac-
tate dehydrogenase, and the results of blood gas analy-
sis. Levels of KL-6 and surfactant protein D （SPD） 
were significantly higher in subacute HP and chronic 
HP than in the other groups.
Measurement of antibody levels
The results of antibody levels against pigeons and 
budgerigars in each disease group are shown in Table 
3 . The mean value of anti-pigeon IgG antibodies was 
significantly elevated in chronic HP compared with 
other groups （Figure 1）. The mean value of anti-bud-
gerigar IgG antibodies was significantly elevated in 
chronic HP compared with chronic IP and control dis-
eases （Figure 2）. 
Correlation between IgG against pigeons and IgG 
against budgerigars （Figure 3）
There was a positive correlation between anti-pi-
geon IgG antibody levels and anti-budgerigar IgG anti-
body levels （R2＝0.715, p＜0.001）. 
DISCUSSION
Many interstitial lung diseases, including collagen 
vascular disease associated with ILD, pneumoconiosis, 
drug-induced pneumonitis, radiation pneumonitis, and 
chronic HP must be excluded in the differential diag-
nosis of “idiopathic” IP3,8〜10）. In addition, some cases of 
chronic BRHP may be misdiagnosed as IIPs or chronic 
IP. We performed this study to attempt to identify fac-
tors useful for differential diagnosis.
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Table 1　Characteristics of patients and baseline data
Characteristics
IPF
n＝22
CIP
n＝8
SHP
n＝7
CHP
n＝7
Control diseases
n＝10
Age, yr, median
（range）
65.8
（47-79）
67.5
（54-80）
53.9
（39-66）
63.4
（57-76）
58.9
（30-78）
Male/female 16/6 3/5 3/4 4/3 6/4
Symptom duration, yr
（range）
2.5±1.1
（1-5）
1.6±0.7
（1-3）
0.8±0.3
（0.5-1.2）
2±0.8
（1-3）
0.8±1.5
（0.1-5）
Ever smoker （％） 19 （86） 4 （50） 4 （57） 5 （71） 6 （60）
Antigen identified （％） 0 （0） 0 （0） 2 （29） 0 （0） 0 （0）
Bird fancier （％） 2 （9） 1 （13） 2 （29） 4 （57） 1 （10）
Use of feather bedclothes （％） 5 （23） 3 （38） 2 （29） 3 （43） 3 （30）
Physical finfdings
Crackles （％）
Clubbed finger （％）
20 （91）
16 （73）
6 （75）
4 （50）
3 （43）
1 （14）
6 （86）
6 （86）
2 （20）
2 （20）
VC ％ predicted 66±17 83±29 92±16 ＊ 79±13 85±33
FEV1/FVC, ％ 113±12 114±10 104±12 110±8 93±17
DLco ％ predicted 55±11 64±12 60±12 60±16 89±39
Data are presented as mean±SD or No. （％） unless otherwise indicated.
Definition of abbreviations：IPF, idiopathic pulmonary fibrosis；CIP, chronic interstitial 
pneumonia；SHP, subacute hypersensitivity pneumonitis；CHP, chronic hypersensitivity 
pneumonitis；FVC, forced vital capacity；FEV1, forced expiratory volume in 1 second；DLco, 
diffusing capacity for carbon monoxide.
＊p＜0.05 compared with IPF.
Table 2　Laboratory findings at diagnosis
Characteristics
IPF
n＝22
CIP
n＝8
SHP
n＝7
CHP
n＝7
Control diseases
n＝10
CRP （mg/dl） 0.61±0.56 0.70±0.73 0.65±0.60 0.37±0.34 2.34±3.14
WBC （/m l） 8753±2567 6686±1120 7357±2118 5400±395 7090±2353
LDH （IU/l） 259±43 245±33 279±41 291±51 242±127
KL-6 （U/ml） 1540±932 1869±1201 5926±3651 ＊† 6089±3791 ＊† 528±228
SPD （ng/ml） 202±100 114±38 470±326 ＊† 816±769 ＊† 134±77
PaO2 （Torr） 73.1±12.2 74.3±8.3 73.9±7.8 74.2±10.6 79.8±12.7
PaCO2 （Torr） 38.6±4.3 36.1±4.4 38.2±1.9 37.0±6.1 37.4±4.1
Data are presented as mean±SD.
Definition of abbreviations：IPF, idiopathic pulmonary fibrosis；CIP, chronic interstitial pneumonia；
SHP, subacute hypersensitivity pneumonitis；CHP, chronic hypersensitivity pneumonitis；CRP, 
C-reactive protein；WBC, white blood cells；LDH, lactate dehydrogenase；KL-6, Krebs von den 
Lungen-6；SPD, surfactant protein D.
＊p＜0.05 compared with IPF, †p＜0.05 compared with CIP.
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BALF findings are considered useful for differentiating 
chronic HP from other types of IP. In many cases, 
however, differential diagnosis of IPF is difficult.
To identify potential causative antigens in HP, proof 
of specific antibodies and positive results for antigen-
induced lymphocyte proliferation, environmental expo-
sure, and antigen provocation are considered immuno-
logically important, but these specialized tests are 
often not possible in general practice. Therefore, it is 
frequently difficult to conclusively determine the caus-
ative antigen. Some cases of chronic HP have been 
On general medical examinations, there were no sig-
nificant differences among the disease groups in C-re-
active protein, leukocyte count, lactate dehydrogenase 
and the results of blood gas analysis, whereas KL-6 
and SPD levels were significantly elevated in subacute 
HP and chronic HP. High levels of KL-6 and SPD were 
considered to suggest the possible diagnosis of HP. 
Chest HRCT findings, such as centrilobular fine granu-
lar opacity, ground-grass opacity, intraseptal thicken-
ing, traction bronchiectasis, intralobular reticular opac-
ity, and honeycombing, pathological findings, and 
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Table 3　 Serum IgG antibodies against pigeons and budgerigars in IPF, CIP, SHP, CHP, and Control 
diseases
Serum IgG
antibody
IPF
n＝22
CIP
n＝8
SHP
n＝7
CHP
n＝7
Control diseases
n＝10
against pigeons
（mg/l）
11.02±5.97 10.04±8.55 14.39±9.13 24.97±16.19 ＊†‡ 8.66±3.15
against budgerigars
（mg/l）
5.03±3.97 3.30±1.47 7.96±6.47 11.50±13.80†¶ 3.77±1.05
Data are presented as mean±SD.
For definition of abbreviations, see Table 1.
＊p＜0.05 compared with IPF, †p＜0.05 compared with CIP, ¶p＜0.05 compared with Control diseases,  
‡p＜0.01 compared with Control diseases.
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Figure 1　Serum IgG antibodies against pigeons
For definition of abbreviations, see Table 1.
＊p＜0.05, ‡p＜0.01.
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of contact with birds thus has an important role in the 
diagnosis of chronic HP. However, a history of contact 
with birds might be overlooked, especially in patients 
with chronic disease.
Components of the excreta of various birds may 
cross-react as antigens14〜17）. In this study, there was a 
strong positive correlation between anti-pigeon IgG 
antibody levels and anti-budgerigar IgG antibody lev-
recognized to be caused by bird-related antigens （bird 
waste products such as feathers or intestinal mucin 
contained in discharges）. Potential causes of chronic 
BRHP include pigeons breeding in the neighborhood11）, 
use of feather duvets12）, and pigeons gathering in near-
by parks13）. A past history of bird breeding has been 
reported to be a more important factor than current 
bird breeding3）. Careful review of the patient’s history 
44 DJMS
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Figure 3　 Correlation between IgG antibodies against pigeons and 
IgG antibodies against budgerigars in all subjects
R2＝0.715, p＜0.001.
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els, suggesting that a suspected diagnosis of BRHP 
may only require the measurement of anti-pigeon IgG 
antibody. Among the different disease groups studied, 
anti-pigeon IgG antibody levels and anti-budgerigar 
IgG antibody levels were significantly elevated in pa-
tients with chronic HP. Some cases of chronic BRHP 
might be included among patients with a clinical diag-
nosis of chronic HP.
Levels of anti-pigeon IgG and anti-budgerigar IgG 
antibodies should be measured in healthy subjects 
with a history of contact with birds, bird breeding, and 
feather comforter use. We measured IgG antibody in 
10 subjects with control diseases （lung cancer, pneu-
monia, and COPD）. The mean anti-pigeon IgG anti-
body level was 8.66±3.15 mg/l, and the anti-budgeri-
gar IgG antibody level was 3 . 7 7±1 . 0 5 mg/l. In a 
previous study, the mean anti-pigeon IgG antibody 
level in 42 healthy individuals was 6.64 mg/l, and the 
cutoff value was less than 20 mg/l 18）. Another study 
reported that the cutoff level of anti-pigeon IgG anti-
bodies was 9.8 mg/l in 73 healthy individuals5）. Consis-
tent with our results, the anti-pigeon IgG antibody 
level in healthy subjects was not considered high.
Although IgG is usually measured as a specific anti-
body in HP, IgA can also be positive in this disease19）. 
In general, IgA plays an important role in airway im-
munity. Antigen-specific IgA is measured in serum or 
in BALF in HP19,20）. In BRHP, the sensitivity and speci-
ficity of the IgG antibody level are equal to or higher 
than those of the IgA antibody level. Consequently, the 
value of additionally measuring IgA is considered mini-
mal21）. 
Among the patients with a clinical diagnosis of IPF, 
3 （14％） had an anti-pigeon IgG antibody level higher 
than 20 mg/l. The past history of contact with birds 
was uncertain among these patients, and some of those 
with a clinical diagnosis of IPF might have had chronic 
BRHP. In the future, anti-pigeon IgG antibody or anti-
budgerigar IgG antibody levels should be measured, 
and detailed interviews should be conducted to ascer-
tain the history of contact with birds in patients who 
are tentatively given a diagnosis IP of unknown etiolo-
gy. Elevated levels of these antibodies suggest the pos-
sibility of BRHP, especially in patients with IP who 
have a history of contact with birds.
Our study had an important limitation. We could not 
have confirmed immunological antigen provocation 
tests in patients with elevated levels of serum bird-
specific IgG antibodies. The final definitive diagnosis of 
BRHP in our patients was still uncertain. If possible, it 
is useful to perform examinations such as pigeon se-
rum-induced lymphocyte proliferation tests, antigen 
inhalation provocation tests of pigeon fecal extracts, 
and environmental exposure tests. The positive results 
of such tests will most likely contribute to the identifi-
cation of etiologic agents and to diagnose BRHP.
In conclusion, high levels of anti-pigeon IgG antibod-
ies or anti-budgerigar IgG antibodies were demon-
strated using an ImmunoCAP analysis system in pa-
tients with a clinical diagnosis of chronic HP. In 
general, HP, especially chronic type, is difficult to de-
finitively diagnose, and this analysis system is expect-
ed to increase the accuracy of diagnosis. Avoidance of 
bird-related antigens might improve the outcomes of 
some cases of chronic HP.
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